Market research
AVCR.V Avricore Health Inc
V CAD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 8M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.32
Profile
Company facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- CA0545211090
- Market cap
- 8M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.32
About
About Avricore Health Inc
Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the AVCR.V discussion.
5 years, 5 months ago
Avricore Health Inc is currently in a long term downtrend where the price is trading 1.2% below its 200 day moving average.
From a valuation standpoint, the stock is 60.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 402.7.
Avricore Health Inc's total revenue sank by 50.2% to $8K since the same quarter in the previous year.
Its net income has increased by 69.7% to $-207K since the same quarter in the previous year.
Finally, its free cash flow grew by 41.4% to $-180K since the same quarter in the previous year.
Based on the above factors, Avricore Health Inc gets an overall score of 3/5.